GNF2133 is a potent, selective, orally active DYRK1A inhibitor with IC50s of 0.0062 and >50 µM for DYRK1A and GSK3beta, respectively. GNF2133 has potential for the study of type 1 diabetes.
Molecular Weight:
434.53
Purity:
>98.5%
CAS Number:
[2561414-56-8]
Formula:
C24H30N6O2
Target:
DYRK
* VAT and and shipping costs not included. Errors and price changes excepted